150 related articles for article (PubMed ID: 35754191)
1. Dual effect of radiotherapy related concomitant cardiovascular diseases in non-small cell lung cancer.
Mo Y; Tian B; Wu M; Chen M; Chen D; Yu J
Cancer Med; 2023 Jan; 12(2):1025-1034. PubMed ID: 35754191
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer.
Sun JY; Zhang ZY; Qu Q; Wang N; Zhang YM; Miao LF; Wang J; Wu LD; Liu Y; Zhang CY; Wang RX
Int J Cardiol; 2021 May; 330():186-193. PubMed ID: 33581175
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.
Borkenhagen JF; Bergom C; Rapp CT; Klawikowski SJ; Rein LE; Gore EM
Clin Lung Cancer; 2019 Nov; 20(6):435-441. PubMed ID: 31303452
[TBL] [Abstract][Full Text] [Related]
5. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database.
Lally BE; Detterbeck FC; Geiger AM; Thomas CR; Machtay M; Miller AA; Wilson LD; Oaks TE; Petty WJ; Robbins ME; Blackstock AW
Cancer; 2007 Aug; 110(4):911-7. PubMed ID: 17620279
[TBL] [Abstract][Full Text] [Related]
6. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Sun X; Men Y; Wang J; Bao Y; Yang X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
Thorac Cancer; 2021 May; 12(9):1358-1365. PubMed ID: 33728811
[TBL] [Abstract][Full Text] [Related]
7. Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer.
Contreras JA; Lin AJ; Weiner A; Speirs C; Samson P; Mullen D; Campian J; Bradley J; Roach M; Robinson C
Radiother Oncol; 2018 Sep; 128(3):498-504. PubMed ID: 29859754
[TBL] [Abstract][Full Text] [Related]
8. Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database.
Wang X; Song J; Long J; Zeng Z; Liu A
Radiat Oncol; 2021 Sep; 16(1):184. PubMed ID: 34544464
[TBL] [Abstract][Full Text] [Related]
9. Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer.
Batra A; Sheka D; Kong S; Cheung WY
BMC Cancer; 2020 Oct; 20(1):1004. PubMed ID: 33059611
[TBL] [Abstract][Full Text] [Related]
10. Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy.
Kim H; Yoo H; Pyo H; Ahn YC; Noh JM; Ju SG; Lee W; Park B; Kim JM; Kang N; Shin SH; Chung MP; Shin S; Kim HS; Park M; Park HY
Int J Chron Obstruct Pulmon Dis; 2019; 14():2273-2281. PubMed ID: 31631997
[TBL] [Abstract][Full Text] [Related]
11. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?
Sun F; Franks K; Murray L; Lilley J; Wheller B; Banfill K; McWilliam A; Abravan A; Van Herk M; Faivre-Finn C; Cubbon R
Lung Cancer; 2020 Aug; 146():1-5. PubMed ID: 32460218
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
Wang X; Yin C; Su S; Li X; Wang C; Zhang C; Liu M
BMC Cancer; 2018 Nov; 18(1):1067. PubMed ID: 30400782
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis.
Kravchenko J; Berry M; Arbeev K; Lyerly HK; Yashin A; Akushevich I
Lung Cancer; 2015 Apr; 88(1):85-93. PubMed ID: 25704956
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
Wang K; Eblan MJ; Deal AM; Lipner M; Zagar TM; Wang Y; Mavroidis P; Lee CB; Jensen BC; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
J Clin Oncol; 2017 May; 35(13):1387-1394. PubMed ID: 28113017
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of PD-1/PD-L1 inhibitors combined with radiotherapy in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Geng Y; Zhang Q; Feng S; Li C; Wang L; Zhao X; Yang Z; Li Z; Luo H; Liu R; Lu B; Wang X
Cancer Med; 2021 Feb; 10(4):1222-1239. PubMed ID: 33465302
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database.
Chen D; Yu J
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833420
[No Abstract] [Full Text] [Related]
18. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
Reboul FL
Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
[TBL] [Abstract][Full Text] [Related]
19. Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort.
Obi N; Eulenburg C; Seibold P; Eilber U; Thöne K; Behrens S; Chang-Claude J; Flesch-Janys D
Breast; 2018 Apr; 38():75-80. PubMed ID: 29248876
[TBL] [Abstract][Full Text] [Related]
20. The risks and trends of cardiac-specific mortality associated with chemotherapy or radiotherapy in a large cohort of non-elderly patients with non-small cell lung cancer.
Jiang KT; Huang DZ
Transl Cancer Res; 2021 Feb; 10(2):842-853. PubMed ID: 35116414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
